CID 132840

Ripisartan

Structural Information

Molecular Formula
C23H22N8O
SMILES
CCCC1=C(C2=NC(=O)NN2C(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
InChI
InChI=1S/C23H22N8O/c1-3-6-20-19(22-25-23(32)28-31(22)14(2)24-20)13-15-9-11-16(12-10-15)17-7-4-5-8-18(17)21-26-29-30-27-21/h4-5,7-12H,3,6,13H2,1-2H3,(H,28,32)(H,26,27,29,30)
InChIKey
OLJAPHMBAMBVKL-UHFFFAOYSA-N
Compound name
5-methyl-7-propyl-8-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-3H-[1,2,4]triazolo[1,5-c]pyrimidin-2-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

15
References

1419
Patents

426.19165 Da
Monoisotopic Mass

3.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 427.19893 205.5
[M+Na]+ 449.18087 216.9
[M-H]- 425.18437 208.9
[M+NH4]+ 444.22547 207.7
[M+K]+ 465.15481 205.6
[M+H-H2O]+ 409.18891 192.4
[M+HCOO]- 471.18985 217.9
[M+CH3COO]- 485.20550 212.3
[M+Na-2H]- 447.16632 204.9
[M]+ 426.19110 207.3
[M]- 426.19220 207.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe